Method and Formulations for Treating Candidiasis Using Morinda Citrifolia

Abstract

The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia -based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.

1 - 18 . (canceled) 
   
   
       19 . A method for inducing antimicrobial activity within the body of a mammal to inhibit, prevent, and destroy  Candida  fungus and the overgrowth of  Candida albicans , said method comprising the steps of:
 adding a processed  Morinda citrifolia  product to an alcohol-based solution;   isolating and extracting an active ingredient of said processed  Morinda citrifolia  product from said solution and incorporating said active ingredient in a naturaceutical formulation; and   introducing a safe, pre-determined amount of said naturaceutical formulation having a safe, pre-determined concentration of said extracted active ingredient to an area infected with said  Candida  fungus intermittently for a safe, pre-identified amount of time.   
   
   
       20 . The method of  claim 19 , wherein said processed  Morinda citrifolia  product comprises processed  Morinda citrifolia  fruit juice. 
   
   
       21 . The method of  claim 19 , wherein said processed  Morinda citrifolia  food product comprises processed  Morinda citrifolia  puree juice. 
   
   
       22 . The method of  claim 19 , wherein said alcohol-based solution is selected from the group consisting essentially of methanol, ethanol, and ethyl acetate, and other alcohol-based solutions. 
   
   
       23 . The method of  claim 19 , wherein said active ingredient is Quercetin. 
   
   
       24 . The method of  claim 23 , wherein said active ingredient is Rutin that synergistically works with said Quercetin to induce antimicrobial activity, thus inhibiting and preventing the overgrowth of said  Candida albicans  in said infected area. 
   
   
       25 . The method of  claim 19 , wherein said step of introducing said extracted active ingredient to an area infected by said  Candida albicans  comprises orally administering two ounces of said naturaceutical formulation to a patient twice daily each day on an empty stomach, said naturaceutical formulation comprising said active ingredient as obtained from said processed  Morinda citrifolia  product. 
   
   
       26 . The method of  claim 19 , wherein said step of introducing said extracted active ingredient to an area infected by said  Candida albicans  comprises applying said naturaceutical formulation topically to said area, said naturaceutical formulation embodied in a topical dermal naturaceutical composition comprising said active ingredient as obtained from said processed  Morinda citrifolia  product. 
   
   
       27 . A method for inhibiting, preventing, and destroying the growth of  candida albicans , said method comprising the steps of:
 orally administering at least one ounce of a naturaceutical formulation comprising a processed  Morinda citrifolia  product on an empty stomach in the morning; and   orally administering at least one ounce of said naturaceutical formulation on an empty stomach prior to sleeping at night.   
   
   
       28 . The method of  claim 27 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight of about 100 percent.   
   
   
       29 . The method of  claim 27 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 10-99.99 percent; and   water present in an amount by weight between about 0.1-90 percent.   
   
   
       30 . The method of  claim 27 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 10-99.9 percent; and   other fruit juices present in an amount by weight between about 0.1-90 percent.   
   
   
       31 . The method of  claim 27 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 50-90 percent;   water present in an amount by weight between about 0.1-50 percent; and   other fruit juices present in an amount between about 0.1-30 percent.   
   
   
       32 . The method of  claim 27 , wherein said overgrowth of said  Candida albicans  is exhibited by vaginal itching, vaginal burning, vaginal redness, vaginal inflammation and vaginal irritation. 
   
   
       33 . The method of  claim 27 , wherein said naturaceutical formulation is consumed by orally administering 2 ounces of said naturaceutical formulation twice daily. 
   
   
       34 . A method for treating Candidiasis comprising the steps of:
 orally administering at least one ounce of a naturaceutical formulation on an empty stomach in the morning, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product;   orally administering at least one ounce of said naturaceutical formulation prior to sleeping at night; and   repeating said steps of orally administering daily until growth of said Candidiasis is abated.   
   
   
       35 . The method of  claim 34 , wherein said naturaceutical formulation comprises processed  Morinda citrifolia  puree juice present in an amount by weight of about 100 percent. 
   
   
       36 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  puree juice present in an amount by weight between about 85-99.99 percent; and   water present in an amount by weight between about 0.1-15 percent.   
   
   
       37 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  puree juice present in an amount by weight between about 85-99.99 percent; and   other fruit juices present in an amount by weight between about 0.1-15 percent.   
   
   
       38 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  puree juice present in an amount by weight between about 50-90 percent;   water present in an amount by weight between about 0.1-50 percent; and   other fruit juices present in an amount between about 0.1-30 percent.   
   
   
       39 . The method of  claim 34 , wherein said naturaceutical formulation is consumed by orally administering 2 ounces of said food product, twice daily. 
   
   
       40 . The method of  claim 34 , wherein said naturaceutical formulation comprises processed  Morinda citrifolia  fruit juice present in an amount by weight of about 100 percent. 
   
   
       41 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 85-99.99 percent; and   water present in an amount by weight between about 0.1-15 percent.   
   
   
       42 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 85-99.99 percent; and   other fruit juices present in an amount by weight between about 0.1-15 percent.   
   
   
       43 . The method of  claim 34 , wherein said naturaceutical formulation comprises:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 50-90 percent;   water present in an amount by weight between about 0.1-50 percent; and   other fruit juices present in an amount between about 0.1-30 percent.   
   
   
       44 . A method for treating Candidiasis, said method comprising the step of:
 topically introducing a portion of a naturaceutical formulation to an area infected with said Candidiasis intermittently each day until growth is abated, said naturaceutical formulation comprising at least one processed  Morinda citrifolia  product.   
   
   
       45 . A method for relieving vaginal discomfort, including itching and swelling, caused by  Candida albicans , said method comprising the steps of:
 orally administering at least one ounce of a naturaceutical formulation comprising at least one processed  Morinda citrifolia  product on an empty stomach in the morning;   orally administering at least one ounce of said naturaceutical formulation prior to sleeping at night; and   repeating said steps of orally administering daily until growth is abated.   
   
   
       46 . The method of  claim 45 , wherein said vaginal discomfort includes vaginal itching, vaginal burning, vaginal redness, vaginal inflammation and vaginal irritation. 
   
   
       47 . The method of  claim 45 , wherein said vaginal discomfort is experienced during pregnancy. 
   
   
       48 . The method of  claim 45 , wherein said vaginal discomfort is experienced by a person taking prescription medications. 
   
   
       49 . A method for inhibiting, preventing, and destroying the growth of  Candida albicans , said method comprising the steps of:
 applying a topical naturaceutical formulation to an area infected with said  Candida albicans , said topical naturaceutical formulation comprising the ingredients of:
 a processed  Morinda citrifolia  product present in an amount by weight between about 10-80 percent; and 
   a carrier composition present in an amount by weight between about 20-90 percent.   
   
   
       50 . The method of  claim 49 , wherein said processed  Morinda citrifolia  product comprises processed  Morinda citrifolia  fruit juice. 
   
   
       51 . The method of  claim 49 , wherein said processed  Morinda citrifolia  product comprises processed  Morinda citrifolia  puree juice. 
   
   
       52 . The method of  claim 49 , wherein said processed  Morinda citrifolia  product comprises processed  Morinda citrifolia  dietary fiber. 
   
   
       53 . The method of  claim 49 , wherein said processed  Morinda citrifolia  product comprises processed  Morinda citrifolia  oil extract. 
   
   
       54 . A method for inhibiting, preventing, and destroying the growth of  Candida albicans , said method comprising the steps of:
 applying a topical naturaceutical formulation to an area infected with said  Candida albicans , said topical naturaceutical formulation comprising the ingredients of:
 processed  Morinda citrifolia  oil present in an amount by weight between about 0.1-20 percent; and 
   a carrier composition present in an amount by weight between about 20-99.99 percent.   
   
   
       55 . A method for inhibiting, preventing, and destroying the growth of  Candida albicans , said method comprising the steps of:
 applying a topical naturaceutical formulation to an area infected with said  Candida albicans , said topical naturaceutical formulation comprising the ingredients of:
 processed  Morinda citrifolia  fruit juice present in an amount by weight between about 0.1-80 percent; 
 processed  Morinda citrifolia  oil present in an amount by weight between about 0.1-20 percent; and 
   a carrier composition present in an amount by weight between about 20-90 percent.   
   
   
       56 - 79 . (canceled)